Skip to main content
. Author manuscript; available in PMC: 2023 May 29.
Published in final edited form as: ACS Infect Dis. 2021 Sep 21;7(10):2850–2863. doi: 10.1021/acsinfecdis.1c00213

Figure 2.

Figure 2.

(A) Lung to plasma ratio. Exposure ratios were determined as ratios between area-under-the-concentration–time curve (AUClast) between lung homogenate and plasma. (B) ELF to plasma ratio. ELF and plasma after different doses (in mg/kg) and dosing regimens of spectinamide-1599 after IPA administration compared to IV and SC administration in mice.